Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01942980 : Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Age > or equal 18 years old,

- Single brain metastasis from breast cancer, first cerebral event,

- Complete surgical resection of cerebral metastasis,

- Histological confirmation of brain metastasis of breast cancer,

- Start of radiotherapy within 6 weeks after surgery,

- Karnofsky > or equal to 70,

- No history of brain radiotherapy,

- Signed informed consent to participate,

- Patient affiliated to a social security system or benefiting from such a system.

Exclusion Criteria:

- Multiple brain metastases, leptomeningeal metastases,

- macroscopic metastasis surgery not complete,

- Warning signs of brain displacement (uncontrolled oedema),

- History of cerebral irradiation or absence of surgical treatment of the current
metastasis,

- History of cancer in the previous 5 years prior to entry in the study, other than
cutaneous basal cell carcinoma or in situ epithelioma of uterine cervix or the stated
breast cancer,

- MMSE (Mini Mental State Examination)< 24,

- all previous systemic treatments less than 2 weeks are not allowed,

- Pregnant women or liable to become pregnant, lactating women,

- Persons deprived of their freedom or under tutelage

- Patients unable to comply with medical procedures of the study for geographical,
social, or psychological reasons.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01942980      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740